Georg Fuellen
Overview
Explore the profile of Georg Fuellen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unfried M, Schmauck-Medina T, Amin N, Boyden E, Fuellen G, Han J, et al.
NPJ Aging
. 2025 Feb;
11(1):8.
PMID: 39966395
No abstract available.
2.
Nolte T, Halabian R, Israel S, Suzuki Y, Avelar R, Palmer D, et al.
Mol Hum Reprod
. 2025 Jan;
31(1.
PMID: 39786543
Recent advances in embryology have shown that the sister blastomeres of two-cell mouse and human embryos differ reciprocally in potency. An open question is whether the blastomeres became different as...
3.
Meiners F, Kreikemeyer B, Newels P, Zude I, Walter M, Hartmann A, et al.
Microbiol Spectr
. 2025 Jan;
13(2):e0191324.
PMID: 39772703
The gut microbiome is amenable to dietary interventions, and polyphenol-rich diets have been shown to enhance abundances of bacteria associated with short-chain fatty acid (SCFA) production. We examined the effects...
4.
Fuellen G, Kulaga A, Lobentanzer S, Unfried M, Avelar R, Palmer D, et al.
Ageing Res Rev
. 2024 Dec;
104:102617.
PMID: 39643211
The field of aging and longevity research is overwhelmed by vast amounts of data, calling for the use of Artificial Intelligence (AI), including Large Language Models (LLMs), for the evaluation...
5.
OSullivan J, Alonso-Perez E, Farber F, Fuellen G, Rudolf H, Heisig J, et al.
Diabetol Metab Syndr
. 2024 Nov;
16(1):291.
PMID: 39609833
Background: Disparities in the development of Type 2 Diabetes (T2D) are associated with various social determinants, including sex/gender, migration background, living arrangement, education, and household income. This study applied an...
6.
Palmer D, Henze L, Murua Escobar H, Walter U, Kowald A, Fuellen G
BMJ Open
. 2024 Sep;
14(9):e088181.
PMID: 39349378
Objectives: To validate and test the generalisability of the SASKit-ML pipeline, a prepublished feature selection and machine learning pipeline for the prediction of health deterioration after a stroke or pancreatic...
7.
Simm A, Grosskopf A, Fuellen G
Z Gerontol Geriatr
. 2024 Aug;
57(5):355-360.
PMID: 39088048
As scientists investigated the molecular mechanisms of the biology of aging, they discovered that these are malleable and can enhance healthy longevity by intervening in the drivers of aging, which...
8.
Huling J, Oschatz S, Lange H, Sterenczak K, Stahnke T, Markhoff J, et al.
Drug Deliv
. 2024 Jun;
31(1):2361168.
PMID: 38899440
Glaucoma is the leading cause of blindness worldwide. However, its surgical treatment, in particular via trabeculectomy, can be complicated by fibrosis. In current clinical practice, application of the drug, Mitomycin...
9.
Revskij D, Woitas A, Kolle B, Umstatter C, Zechner D, Khan F, et al.
Hepatobiliary Pancreat Dis Int
. 2024 Jun;
23(6):628-637.
PMID: 38879414
Background: The combination of senescence triggers with senolytic drugs is considered a promising new approach to cancer therapy. Here, we studied the efficacy of the genotoxic agent etoposide (Eto) and...
10.
Projahn E, Fuellen G, Walter M, Moller S
NAR Genom Bioinform
. 2024 Apr;
6(2):lqae037.
PMID: 38666215
In this paper, we present a comprehensive computational framework aimed at suggesting genes whose transcriptional regulation is likely to be influenced by their chromosomal position. This framework provides a user-friendly...